Prolegomena zu einer kritischen Wernickeausgabe : Einleitung, Abschnitt I und II.

Thesis (doctoral)--Friedrich-Wilhelms-Universitat zu Berlin.

Pirckheimer-Studien : Buch I und II.

Thesis (doctoral)--Friedrich-Wilhelms-Universitat zu Berlin.

Das Unterkonigtum im Reiche der Merovinger und Karolinger : Teil I und II, Abschnitt A, Kapitel 1.

Thesis (doctoral)--Friedrich-Wilhelms-Universitat zu Berlin.

Das Amt Bergedorf Geschichte seiner Verfassung und Verwaltung bis 1620 : I. und II. Teil.

Thesis (doctoral)--Georg-August-Universitat, Gottingen.

Das Ceremoniell der Kaiserkronungen von Otto I. - Friedrich II.

Thesis (doctoral)--K. Bayer. Ludwig-Maximilians-Universitat Munchen.

A compendious system of anatomy : In six parts. Part I. Osteology. II. Of the muscles, &c. III. Of the abdomen. Part IV. Of the thorax. V. Of the brain and nerves. VI. Of the senses. From the Encyclopaedia. Illustrated with twelve large copperplates.

Austin

Fragm. lat. II 57 - Sermones de tempore (Dom. I et II adv.)

Trägerband: Inc. oct. 511; Vorbesitzer: Dominikanerkloster Frankfurt am Main

Studies of the interaction of Potassium(I), Calcium(II), Magnesium(II), and Copper(II) with Cyclosporin A

Metal ion binding properties of the immunosuppressant drug cyclosporin A have been investigated. Complexation studies in acetonitrile solution using H-1 NMR and CD spectroscopy yielded 1:1 metal-peptide binding constants (log(10)K) for potassium(l), < 1, magnesium(II), 4.8 +/- 0.2. and calcium(II), 5.0 +/- 1.0. The interaction of copper(II) with cyclosporin A in methanol was investigated with UV/visible and electron paramagnetic resonance (EPR) spectroscopy. No complexation of copper(II) was observed in neutral solution. In the presence of base, monomeric copper(II) complexes were detected. These results support the possibility that cyclosporin A has ionophoric properties for biologically important essential metal ions. (C) 2003 Elsevier Inc. All rights reserved.

Does chemotherapy improve survival in high-risk Stage I and II Merkel cell carcinoma of the skin?

Purpose: The effectiveness of synchronous carboplatin, etoposide, and radiation therapy in improving survival was evaluated by comparison of a matched set of historic control subjects with patients treated in a prospective Phase II study that used synchronous chemotherapy and radiation and adjuvant chemotherapy. Patients and Methods: Patients were included in the analysis if they had disease localized to the primary site and nodes, and they were required to have at least one of the following high-risk features: recurrence after initial therapy, involved nodes, primary size greater than 1 cm, or gross residual disease after surgery. All patients who received chemotherapy were treated in a standardized fashion as part of a Phase II study (Trans-Tasman Radiation Oncology Group TROG 96:07) from 1997 to 2001. Radiation was delivered to the primary site and nodes to a dose of 50 Gy in 25 fractions over 5 weeks, and synchronous carboplatin (AUC 4.5) and etoposide, 80 mg/m(2) i.v. on Days 1 to 3, were given in Weeks 1, 4, 7, and 10. The historic group represents a single institution's experience from 1988 to 1996 and was treated with surgery and radiation alone, and patients were included if they fulfilled the eligibility criteria of TROG 96:07. Patients with occult cutaneous disease were not included for the purpose of this analysis. Because of imbalances in the prognostic variables between the two treatment groups, comparisons were made by application of Cox's proportional hazard modeling. Overall survival, disease-specific survival, locoregional control, and distant control were used as endpoints for the study. Results: Of the 102 patients who had high-risk Stage I and II disease, 40 were treated with chemotherapy (TROG 96:07) and 62 were treated without chemotherapy (historic control subjects). When Cox's proportional hazards modeling was applied, the only significant factors for overall survival were recurrent disease, age, and the presence of residual disease. For disease-specific survival, recurrent disease was the only significant factor. Primary site on the lower limb had an adverse effect on locoregional control. For distant control, the only significant factor was residual disease. Conclusions: The multivariate analysis suggests chemotherapy has no effect on survival, but because of the wide confidence limits, a chemotherapy effect cannot be excluded. A study of this size is inadequately powered to detect small improvements in survival, and a larger randomized study remains the only way to truly confirm whether chemotherapy improves the results in high-risk MCC. (c) 2006 Elsevier Inc.

Production of triploid Kuruma shrimp, Marsupenaeus (Penaeus) japonicus (Bate) nauplii through inhibition of polar body I, or polar body I and II extrusion using 6-dimethylaminopurine

This study investigated the chromosome ploidy level of Marsupenaeus (Penaeus) japonicus (Bate) non-viable (unhatched) embryos and nauplii after exposure to 6-dimethylaminopurine (6-DMAP), timed to stop either polar body (PB) I, or PBI and II extrusion. Embryos from eight separate families or spawnings were exposed to 150 or 200 mu M 6-DMAP from 1- to 3-min post-spawning detection (psd) for a 4- to 5-min duration (timed to stop PBI extrusion). Separate aliquots of embryos from five of the same spawnings were also exposed to 200 mu M of 6-DMAP from 1- to 3-min psd for a 16-min duration (timed to stop both PBI and II extrusion). For one spawning, a third aliquot of embryos was exposed to 400 p M of 6-DMAP from 1- to 3-min psd for a 16-min duration (timed to stop both PBI and II extrusion). At 18-h psd, non-viable embryo and nauplii samples were taken separately for fluorescent activated cell sorting (FACS). FACS revealed that there were diploids and triploids among all treated non-viable embryos and nauplii. All control non-viable embryos and nauplii were diploid. Percentages of triploid induction for the 4- to 5-min and 16-min durations were not significantly different (P > 0.05). Additionally, no difference was found in the triploidy level of nonviable embryos compared to nauplii in these treatments. The percentage of triploid embryos and nauplii when exposed to 6-DMAP for a 4- to 5-min duration ranged from 29.57% to 99.23% (average 55.28 +/- 5.45%) and from 5.60% to 98.85% (average 46.70 +/- 7.20%), respectively. The percentage of triploid embryos and nauplii when exposed to 6-DMAP for a 16-min duration ranged from 11.71% to 98.96% (average 52.49 +/- 11.00%) and from 47.5% to 99.24% (average 79.38 +/- 5.24%), respectively. To our knowledge, this is the first documentation of successful PBI or PBI and II inhibition in shrimp. This study conclusively shows that treatment of M. japonicus embryos with 6-DMAP at 1- to 3-min pscl for either a 4- to 5-min duration (timed to stop PBl extrusion) or 16-min duration (timed to stop both PBI and II extrusion) results in viable triploid nauplii. (c) 2006 Elsevier B.V. All rights reserved.

Comparação das atividades musculares durante a mastigação nas maloclusões de classe I e II de Angle

O objetivo deste estudo foi comparar a atividade muscular dos músculos da face e pescoço nas maloclusões Classe I e II de Angle, segundo o sexo. A amostra constou de 36 indivíduos, sendo 22 indivíduos com maloclusão classe I com média de idade de 22,4 anos e 14 indivíduos com maloclusão Classe II com média de idade de 22,8 anos. Os registros foram realizados por um eletromiógrafo de superfície, sendo analisada a atividade dos músculos masseter, temporal feixe anterior, esternocleidomastoídeo e digástrico ventre anterior dos lados direito e esquerdo durante a mastigação dos alimentos uva passa, bolacha água e sal e goma de mascar-PLOC. Após análise estatística descritiva e análise de variância os resultados mostraram que houve diferença estatisticamente significante apenas para os músculos: masseter direito durante a mastigação de uva passa quando comparadas as maloclusões de Classe I e II no sexo masculino; para o músculo digástrico direito quando comparado sexo e as maloclusões Classe I e II durante a mastigação dos três alimentos. Por fim, para o músculo digástrico esquerdo durante a mastigação de uva passa também encontramos diferença estatisticamente significante entre os sexos para as maloclusões Classe I e II. Nossos resultados sugerem que dependendo da consistência do alimento o tipo de maloclusão e sexo podem influenciar na atividade muscular durante a função da mastigação.(AU)

Associação do sobrepeso, obesidade I e II e circunferência da cintura com sintomas de ansiedade e depressão

Este estudo objetivou associar o sobrepeso, obesidade I e II e Circunferência da Cintura (CC) com sintomas de ansiedade e depressão em adultos que buscavam primeiro atendimento médico nutricional para emagrecimento em consultório do município de Santos São Paulo - Brasil, mesmo os que já haviam tentado emagrecer anteriormente. Para coletar dados, foi utilizada uma ficha para caracterização do participante, Inventário IDATE para ansiedade traço estado, Inventário de Beck (BDI) para depressão, balança antropométrica para aferição do peso, altura e cálculo do Índice de Massa Corporal (IMC), fita métrica inelástica para aferir CC. Os dados dos 81 participantes demonstraram que 38% eram jovens, 36% casados, 63% possuíam nível superior completo, 45% alta renda familiar. Estavam em sobrepeso 56% e obesidade I 28%, e 64% apresentavam 77 a 100 cm de CC. A análise simples da distribuição dos sintomas de ansiedade e depressão na elevação do IMC e da CC demonstra que, conforme estes aumentam, a ansiedade e depressão diminuem. Houve alta ocorrência de sintomas de ansiedade traço (75%) estado (70%) de intensidade média baixa e de depressão mínima (64%) que decaem de freqüência conforme eleva o IMC e a CC, bem como redução de freqüência às consultas conforme eleva o IMC. Não houve casos de depressão grave. A análise estatística de Pearson não encontrou correlação entre IMC e CC com sintomas de ansiedade e depressão, o mesmo ocorrendo com o teste para associação Qui-quadrado. Os resultados sugerem ocorrer uma acomodação emocional do indivíduo às pressões causadas pela elevação do peso corporal e os participantes apresentavam-se, em sua maioria, hiporreativos, indiferentes ou insensíveis aos acontecimentos, com desinteresse geral ou falta de desejos aparentando resistência ao tratamento e apatia.

Toward the prediction of class I and II mouse major histocompatibility complex-peptide-binding affinity:in silico bioinformatic step-by-step guide using quantitative structure-activity relationships

Quantitative structure-activity relationship (QSAR) analysis is a cornerstone of modern informatics. Predictive computational models of peptide-major histocompatibility complex (MHC)-binding affinity based on QSAR technology have now become important components of modern computational immunovaccinology. Historically, such approaches have been built around semiqualitative, classification methods, but these are now giving way to quantitative regression methods. We review three methods--a 2D-QSAR additive-partial least squares (PLS) and a 3D-QSAR comparative molecular similarity index analysis (CoMSIA) method--which can identify the sequence dependence of peptide-binding specificity for various class I MHC alleles from the reported binding affinities (IC50) of peptide sets. The third method is an iterative self-consistent (ISC) PLS-based additive method, which is a recently developed extension to the additive method for the affinity prediction of class II peptides. The QSAR methods presented here have established themselves as immunoinformatic techniques complementary to existing methodology, useful in the quantitative prediction of binding affinity: current methods for the in silico identification of T-cell epitopes (which form the basis of many vaccines, diagnostics, and reagents) rely on the accurate computational prediction of peptide-MHC affinity. We have reviewed various human and mouse class I and class II allele models. Studied alleles comprise HLA-A*0101, HLA-A*0201, HLA-A*0202, HLA-A*0203, HLA-A*0206, HLA-A*0301, HLA-A*1101, HLA-A*3101, HLA-A*6801, HLA-A*6802, HLA-B*3501, H2-K(k), H2-K(b), H2-D(b) HLA-DRB1*0101, HLA-DRB1*0401, HLA-DRB1*0701, I-A(b), I-A(d), I-A(k), I-A(S), I-E(d), and I-E(k). In this chapter we show a step-by-step guide into predicting the reliability and the resulting models to represent an advance on existing methods. The peptides used in this study are available from the AntiJen database (http://www.jenner.ac.uk/AntiJen). The PLS method is available commercially in the SYBYL molecular modeling software package. The resulting models, which can be used for accurate T-cell epitope prediction, will be made are freely available online at the URL http://www.jenner.ac.uk/MHCPred.

On the use of the type I and II scheme for classifying ultrafast laser direct-write photonics

The use of the Type I and Type II scheme, first introduced and used by fiber Bragg grating researchers, has recently been adopted by the ultrafast laser direct-write photonics community to classify the physical geometry of waveguides written into glasses and crystals. This has created confusion between the fiber Bragg grating and direct-write photonics community. Here we propose a return to the original basis of the classification based on the characteristics of the material modification rather than the physical geometry of the waveguide.